David R. Lynch - Publications

Affiliations: 
Neuroscience University of Pennsylvania, Philadelphia, PA, United States 
Area:
Neuroscience Biology

154 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Blair IA, Farmer J, Hersch S, Larkindale J, Lynch DR, Napierala J, Napierala M, Payne RM, Subramony SH. The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meeting. Future Science Oa. 5: FSO398. PMID 31285843 DOI: 10.2144/fsoa-2019-0026  0.44
2019 Weng L, Wang Q, Yu S, Yang X, Lynch DR, Mesaros C, Blair IA. Evaluation of antibodies for western blot analysis of frataxin protein isoforms. Journal of Immunological Methods. PMID 31279523 DOI: 10.1016/j.jim.2019.07.001  0.44
2019 Patel M, Schadt K, McCormick A, Isaacs C, Dong YN, Lynch DR. Open label Pilot Study of Oral Methylprednisolone for the Treatment of Patients with Friedreich Ataxia. Muscle & Nerve. PMID 31206761 DOI: 10.1002/mus.26610  0.32
2019 Lynch DR, Hauser L, McCormick A, Wells M, Dong YN, McCormack S, Schadt K, Perlman S, Subramony SH, Mathews KD, Brocht A, Ball J, Perdok R, Grahn A, Vescio T, et al. Randomized, double-blind, placebo-controlled study of interferon- 1b in Friedreich Ataxia. Annals of Clinical and Translational Neurology. 6: 546-553. PMID 30911578 DOI: 10.1002/acn3.731  0.4
2019 Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA. Correction to Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia. Analytical Chemistry. PMID 30676739 DOI: 10.1021/acs.analchem.9b00141  0.44
2019 Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, Snyder N, Boesch S, Chin M, Delatycki MB, Giunti P, Goldsberry A, Hoyle C, McBride MG, Nachbauer W, et al. Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia. Annals of Clinical and Translational Neurology. 6: 15-26. PMID 30656180 DOI: 10.1002/acn3.660  0.44
2018 Dong YN, McMillian E, Clark EM, Lin H, Lynch DR. GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich Ataxia cellular models. Human Molecular Genetics. PMID 30590615 DOI: 10.1093/hmg/ddy448  0.32
2018 Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Mesaros C, Lynch DR, Blair IA. Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes. Scientific Reports. 8: 17043. PMID 30451920 DOI: 10.1038/s41598-018-35346-y  0.44
2018 Sharma R, Al-Saleem FH, Puligedda RD, Rattelle A, Lynch DR, Dessain SK. Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis. Bmc Biotechnology. 18: 41. PMID 29945600 DOI: 10.1186/s12896-018-0450-1  0.32
2018 Salovin A, Glanzman J, Roslin K, Armangue T, Lynch DR, Panzer JA. Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e458. PMID 29629396 DOI: 10.1212/NXI.0000000000000458  0.64
2018 Ejaz R, Chen S, Isaacs CJ, Carnevale A, Wilson J, George K, Delatycki MB, Perlman SL, Mathews KD, Wilmot GR, Hoyle JC, Subramony SH, Zesiewicz T, Farmer JM, Lynch DR, et al. Impact of Mobility Device Use on Quality of Life in Children With Friedreich Ataxia. Journal of Child Neurology. 883073818764941. PMID 29607705 DOI: 10.1177/0883073818764941  0.4
2018 Wang Q, Guo L, Strawser CJ, Hauser LA, Hwang WT, Snyder NW, Lynch DR, Mesaros C, Blair IA. Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy. Plos One. 13: e0192779. PMID 29447225 DOI: 10.1371/journal.pone.0192779  0.44
2018 Lin H, Magrane J, Rattelle A, Stepanova A, Galkin A, Clark EM, Dong YN, Halawani SM, Lynch DR. Correction: Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia (doi: 10.1242/dmm.030502). Disease Models & Mechanisms. 11. PMID 29419392 DOI: 10.1242/dmm.033415  0.32
2018 Lynch DR, Rattelle A, Dong YN, Roslin K, Gleichman AJ, Panzer JA. Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms. Advances in Pharmacology (San Diego, Calif.). 82: 235-260. PMID 29413523 DOI: 10.1016/bs.apha.2017.08.005  0.72
2017 Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros CA, Lynch DR, Blair IA. Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia. Analytical Chemistry. PMID 29272104 DOI: 10.1021/acs.analchem.7b04590  0.44
2017 Lin H, Magrane J, Clark EM, Halawani SM, Warren N, Rattelle A, Lynch DR. Early VGLUT1-specific parallel fiber synaptic deficits and dysregulated cerebellar circuit in the KIKO mouse model of Friedreich ataxia. Disease Models & Mechanisms. 10: 1529-1538. PMID 29259026 DOI: 10.1242/dmm.030049  0.32
2017 Lin H, Magrane J, Rattelle A, Stepanova A, Galkin A, Clark EM, Dong YN, Halawani SM, Lynch DR. Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia. Disease Models & Mechanisms. 10: 1343-1352. PMID 29125827 DOI: 10.1242/dmm.030502  0.32
2016 Panzer JA, Anand R, Dalmau J, Lynch DR. Corrigendum to "Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome" [J. Neuroimmunol. 286 (2015) 86-92]. Journal of Neuroimmunology. PMID 27266593 DOI: 10.1016/j.jneuroim.2016.05.001  1
2016 Shinnick JE, Schadt K, Strawser C, Wilcox N, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, Yiu EM, Delatycki MB, Brocht AF, ... ... Lynch DR, et al. Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone Deficiency. Journal of Child Neurology. PMID 27071470 DOI: 10.1177/0883073816643408  1
2016 Isaacs CJ, Brigatti KW, Kucheruk O, Ratcliffe S, Sciascia T, McCormack SE, Willi SM, Lynch DR. Effects of Genetic Severity on Glucose Homeostasis in Friedreich Ataxia. Muscle & Nerve. PMID 27061687 DOI: 10.1002/mus.25136  0.4
2016 Lin H, Jacobi AA, Anderson SA, Lynch DR. D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability. Frontiers in Cellular Neuroscience. 10: 34. PMID 26941605 DOI: 10.3389/fncel.2016.00034  1
2015 Galea CA, Huq A, Lockhart PJ, Tai G, Corben LA, Yiu EM, Gurrin LC, Lynch DR, Gelbard S, Durr A, Pousset F, Parkinson M, Labrum R, Giunti P, Perlman SL, et al. Compound heterozygous FXN mutations and clinical outcome in Friedreich ataxia. Annals of Neurology. PMID 26704351 DOI: 10.1002/ana.24595  0.4
2015 Li Y, Lu Y, Polak U, Lin K, Shen J, Farmer J, Seyer L, Bhalla AD, Rozwadowska N, Lynch DR, Butler JS, Napierala M. Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus. Human Molecular Genetics. PMID 26401053 DOI: 10.1093/hmg/ddv397  1
2015 Lazaropoulos M, Dong Y, Clark E, Greeley NR, Seyer LA, Brigatti KW, Christie C, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, ... ... Lynch DR, et al. Frataxin levels in peripheral tissue in Friedreich ataxia. Annals of Clinical and Translational Neurology. 2: 831-42. PMID 26339677 DOI: 10.1002/acn3.225  0.44
2015 Panzer JA, Anand R, Dalmau J, Lynch DR. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome. Journal of Neuroimmunology. 286: 86-92. PMID 26298330 DOI: 10.1016/j.jneuroim.2015.07.007  1
2015 Worth AJ, Basu SS, Deutsch EC, Hwang WT, Snyder NW, Lynch DR, Blair IA. Stable isotopes and LC-MS for monitoring metabolic disturbances in Friedreich's ataxia platelets. Bioanalysis. 7: 1843-55. PMID 26295986 DOI: 10.4155/bio.15.118  1
2015 Li Y, Polak U, Bhalla AD, Rozwadowska N, Butler JS, Lynch DR, Dent SY, Napierala M. Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1055-65. PMID 25758173 DOI: 10.1038/mt.2015.41  1
2015 Lynch DR, Perlman SL. Friedreich's ataxia: the European consortium. The Lancet. Neurology. 14: 130-1. PMID 25566997 DOI: 10.1016/S1474-4422(14)70327-8  1
2015 Zyskind JW, Wang Y, Cho G, Ting JH, Kolson DL, Lynch DR, Jordan-Sciutto KL. E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity. Journal of Neurochemistry. 132: 742-55. PMID 25279448 DOI: 10.1111/jnc.12956  1
2014 Adang LA, Lynch DR, Panzer JA. Pediatric anti-NMDA receptor encephalitis is seasonal. Annals of Clinical and Translational Neurology. 1: 921-5. PMID 25540806 DOI: 10.1002/acn3.100  0.64
2014 Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, Mollenhauer B, Scherzer CR, Ivinson AJ, Finke C, Schöls L, Müller Vom Hagen J, Trenkwalder C, Jahn H, Höltje M, ... ... Lynch DR, et al. High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Annals of Clinical and Translational Neurology. 1: 822-32. PMID 25493273 DOI: 10.1002/acn3.120  0.64
2014 Lynch DR, Seyer L. Friedreich ataxia: new findings, new challenges. Annals of Neurology. 76: 487-8. PMID 25159691 DOI: 10.1002/ana.24259  1
2014 Strawser CJ, Schadt KA, Lynch DR. Therapeutic approaches for the treatment of Friedreich's ataxia. Expert Review of Neurotherapeutics. 14: 949-57. PMID 25034024 DOI: 10.1586/14737175.2014.939173  1
2014 Lin H, Hsu FC, Baumann BH, Coulter DA, Anderson SA, Lynch DR. Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia. Molecular and Cellular Neurosciences. 61: 163-75. PMID 24983521 DOI: 10.1016/j.mcn.2014.06.007  1
2014 Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. Journal of the Neurological Sciences. 342: 29-35. PMID 24819921 DOI: 10.1016/j.jns.2014.04.015  0.32
2014 Lynch DR, Fischbeck KH. Nicotinamide in Friedreich's ataxia: useful or not? Lancet. 384: 474-5. PMID 24794818 DOI: 10.1016/S0140-6736(14)60573-0  1
2014 Gleichman AJ, Panzer JA, Baumann BH, Dalmau J, Lynch DR. Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis. Annals of Clinical and Translational Neurology. 1: 180-189. PMID 24707504 DOI: 10.1002/acn3.43  0.72
2014 Deutsch EC, Oglesbee D, Greeley NR, Lynch DR. Usefulness of frataxin immunoassays for the diagnosis of Friedreich ataxia. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 994-1002. PMID 24463479 DOI: 10.1136/jnnp-2013-306788  1
2014 Panzer JA, Gleichman AJ, Lynch DR. Glutamatergic autoencephalitides: an emerging field. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 957-68. PMID 24402576 DOI: 10.1007/s00702-013-1152-4  1
2014 Lin H, Hsu FC, Baumann BH, Coulter DA, Lynch DR. Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases. Neurobiology of Disease. 63: 129-40. PMID 24326163 DOI: 10.1016/j.nbd.2013.11.021  1
2014 St John Sutton M, Ky B, Regner SR, Schadt K, Plappert T, He J, D'Souza B, Lynch DR. Longitudinal strain in Friedreich Ataxia: a potential marker for early left ventricular dysfunction. Echocardiography (Mount Kisco, N.Y.). 31: 50-7. PMID 23834395 DOI: 10.1111/echo.12287  1
2013 Basu SS, Deutsch EC, Schmaier AA, Lynch DR, Blair IA. Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS. Bioanalysis. 5: 3009-21. PMID 24320127 DOI: 10.4155/bio.13.269  1
2013 Oglesbee D, Kroll C, Gakh O, Deutsch EC, Lynch DR, Gavrilova R, Tortorelli S, Raymond K, Gavrilov D, Rinaldo P, Matern D, Isaya G. High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood. Clinical Chemistry. 59: 1461-9. PMID 23838345 DOI: 10.1373/clinchem.2013.207472  1
2013 Seyer LA, Galetta K, Wilson J, Sakai R, Perlman S, Mathews K, Wilmot GR, Gomez CM, Ravina B, Zesiewicz T, Bushara KO, Subramony SH, Ashizawa T, Delatycki MB, Brocht A, ... ... Lynch DR, et al. Analysis of the visual system in Friedreich ataxia. Journal of Neurology. 260: 2362-9. PMID 23775342 DOI: 10.1007/s00415-013-6978-z  1
2013 Plasterer HL, Deutsch EC, Belmonte M, Egan E, Lynch DR, Rusche JR. Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia. Plos One. 8: e63958. PMID 23691127 DOI: 10.1371/journal.pone.0063958  1
2013 Panzer JA, Lynch DR. Neuroimmunology: Treatment of anti-NMDA receptor encephalitis--time to be bold? Nature Reviews. Neurology. 9: 187-9. PMID 23458972 DOI: 10.1038/nrneurol.2013.31  1
2013 Metz G, Coppard N, Cooper JM, Delatycki MB, Dürr A, Di Prospero NA, Giunti P, Lynch DR, Schulz JB, Rummey C, Meier T. Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database. Brain : a Journal of Neurology. 136: 259-68. PMID 23365101 DOI: 10.1093/brain/aws309  1
2013 Lynch DR, Pandolfo M, Schulz JB, Perlman S, Delatycki MB, Payne RM, Shaddy R, Fischbeck KH, Farmer J, Kantor P, Raman SV, Hunegs L, Odenkirchen J, Miller K, Kaufmann P. Common data elements for clinical research in Friedreich's ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 190-5. PMID 23239403 DOI: 10.1002/mds.25201  1
2013 McDonald-McGinn DM, Fahiminiya S, Revil T, Nowakowska BA, Suhl J, Bailey A, Mlynarski E, Lynch DR, Yan AC, Bilaniuk LT, Sullivan KE, Warren ST, Emanuel BS, Vermeesch JR, Zackai EH, et al. Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. Journal of Medical Genetics. 50: 80-90. PMID 23231787 DOI: 10.1136/jmedgenet-2012-101320  1
2012 Gleichman AJ, Spruce LA, Dalmau J, Seeholzer SH, Lynch DR. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11082-94. PMID 22875940 DOI: 10.1523/JNEUROSCI.0064-12.2012  1
2012 Ashley CN, Hoang KD, Lynch DR, Perlman SL, Maria BL. Childhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions. Journal of Child Neurology. 27: 1095-120. PMID 22859693 DOI: 10.1177/0883073812448840  0.4
2012 Lynch DR, Deutsch EC, Wilson RB, Tennekoon G. Unanswered questions in Friedreich ataxia. Journal of Child Neurology. 27: 1223-9. PMID 22832776 DOI: 10.1177/0883073812453498  1
2012 Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, ... ... Lynch DR, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Reports. 1: 2-12. PMID 22832103 DOI: 10.1016/j.celrep.2011.11.001  1
2012 Mahishi LH, Hart RP, Lynch DR, Ratan RR. miR-886-3p levels are elevated in Friedreich ataxia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9369-73. PMID 22764244 DOI: 10.1523/JNEUROSCI.0059-12.2012  1
2012 Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, Perlman S, Delatycki M, Wilmot GR, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Ravina B, ... ... Lynch DR, et al. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. Journal of Child Neurology. 27: 1152-8. PMID 22752494 DOI: 10.1177/0883073812448462  1
2012 Brigatti KW, Deutsch EC, Lynch DR, Farmer JM. Novel diagnostic paradigms for Friedreich ataxia. Journal of Child Neurology. 27: 1146-51. PMID 22752491 DOI: 10.1177/0883073812448440  1
2012 Deutsch EC, Seyer LA, Perlman SL, Yu J, Lynch DR. Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma. Journal of Child Neurology. 27: 1159-63. PMID 22752483 DOI: 10.1177/0883073812448460  1
2012 Lynch DR, Willi SM, Wilson RB, Cotticelli MG, Brigatti KW, Deutsch EC, Kucheruk O, Shrader W, Rioux P, Miller G, Hawi A, Sciascia T. A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1026-33. PMID 22744651 DOI: 10.1002/mds.25058  1
2012 Martelli A, Friedman LS, Reutenauer L, Messaddeq N, Perlman SL, Lynch DR, Fedosov K, Schulz JB, Pandolfo M, Puccio H. Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia. Disease Models & Mechanisms. 5: 860-9. PMID 22736457 DOI: 10.1242/dmm.009829  0.4
2012 Evans-Galea MV, Carrodus N, Rowley SM, Corben LA, Tai G, Saffery R, Galati JC, Wong NC, Craig JM, Lynch DR, Regner SR, Brocht AF, Perlman SL, Bushara KO, Gomez CM, et al. FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Annals of Neurology. 71: 487-97. PMID 22522441 DOI: 10.1002/ana.22671  1
2012 Snyder M, Seyer L, Lynch DR, Resnick A, Zesiewicz TA. Cardiac dysfunction exacerbated by endocrinopathies in Friedreich ataxia: a case series. Journal of Child Neurology. 27: 1316-9. PMID 22408141 DOI: 10.1177/0883073811435242  1
2012 Singh P, Doshi S, Spaethling JM, Hockenberry AJ, Patel TP, Geddes-Klein DM, Lynch DR, Meaney DF. N-methyl-D-aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunit. The Journal of Biological Chemistry. 287: 4348-59. PMID 22179603 DOI: 10.1074/jbc.M111.253740  1
2012 Regner SR, Lagedrost SJ, Plappert T, Paulsen EK, Friedman LS, Snyder ML, Perlman SL, Mathews KD, Wilmot GR, Schadt KA, Sutton MS, Lynch DR. Analysis of echocardiograms in a large heterogeneous cohort of patients with friedreich ataxia. The American Journal of Cardiology. 109: 401-5. PMID 22078220 DOI: 10.1016/j.amjcard.2011.09.025  0.4
2012 Meier T, Perlman SL, Rummey C, Coppard NJ, Lynch DR. Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study. Journal of Neurology. 259: 284-91. PMID 21779958 DOI: 10.1007/s00415-011-6174-y  0.4
2011 Coppola G, Burnett R, Perlman S, Versano R, Gao F, Plasterer H, Rai M, Saccá F, Filla A, Lynch DR, Rusche JR, Gottesfeld JM, Pandolfo M, Geschwind DH. A gene expression phenotype in lymphocytes from Friedreich ataxia patients. Annals of Neurology. 70: 790-804. PMID 22162061 DOI: 10.1002/ana.22526  1
2011 Cook DR, Gleichman AJ, Cross SA, Doshi S, Ho W, Jordan-Sciutto KL, Lynch DR, Kolson DL. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. Journal of Neurochemistry. 118: 1113-23. PMID 21749375 DOI: 10.1111/j.1471-4159.2011.07383.x  1
2011 Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, Ravina B, Koeppen AH, Lynch DR. Mortality in Friedreich ataxia. Journal of the Neurological Sciences. 307: 46-9. PMID 21652007 DOI: 10.1016/j.jns.2011.05.023  0.4
2011 Lagedrost SJ, Sutton MS, Cohen MS, Satou GM, Kaufman BD, Perlman SL, Rummey C, Meier T, Lynch DR. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). American Heart Journal. 161: 639-645.e1. PMID 21392622 DOI: 10.1016/j.ahj.2010.10.038  0.4
2011 Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, Selamoglu N, Yager C, Knight S, Carroll M, Daldal F, Dancis A, Lynch DR, Sarry JE. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion. 11: 342-50. PMID 21147271 DOI: 10.1016/j.mito.2010.12.003  1
2010 Lin H, Vicini S, Hsu FC, Doshi S, Takano H, Coulter DA, Lynch DR. Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons. Proceedings of the National Academy of Sciences of the United States of America. 107: 16661-6. PMID 20817852 DOI: 10.1073/pnas.1007397107  1
2010 Lynch DR, Perlman SL, Meier T. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Archives of Neurology. 67: 941-7. PMID 20697044 DOI: 10.1001/archneurol.2010.168  1
2010 Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, Lynch DR. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Molecular Genetics and Metabolism. 101: 238-45. PMID 20675166 DOI: 10.1016/j.ymgme.2010.07.001  1
2010 Friedman LS, Paulsen EK, Schadt KA, Brigatti KW, Driscoll DA, Farmer JM, Lynch DR. Pregnancy with Friedreich ataxia: a retrospective review of medical risks and psychosocial implications. American Journal of Obstetrics and Gynecology. 203: 224.e1-5. PMID 20478553 DOI: 10.1016/j.ajog.2010.03.046  1
2010 Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 5866-75. PMID 20427647 DOI: 10.1523/JNEUROSCI.0167-10.2010  1
2010 Paulsen EK, Friedman LS, Myers LM, Lynch DR. Health-related quality of life in children with Friedreich ataxia. Pediatric Neurology. 42: 335-7. PMID 20399387 DOI: 10.1016/j.pediatrneurol.2010.01.002  1
2010 Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 426-32. PMID 20063431 DOI: 10.1002/mds.22912  1
2010 Singh A, Epstein E, Myers LM, Farmer JM, Lynch DR. Clinical measures of dysarthria in Friedreich Ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 108-11. PMID 20014117 DOI: 10.1002/mds.22776  1
2009 Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Annals of Neurology. 66: 11-8. PMID 19670433 DOI: 10.1002/ana.21756  1
2009 Zesiewicz TA, Sullivan KL, Gooch CL, Lynch DR. Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix). Journal of Clinical Neuromuscular Disease. 10: 191-3. PMID 19494730 DOI: 10.1097/CND.0b013e3181910074  1
2009 Doshi S, Lynch DR. Calpain and the glutamatergic synapse. Frontiers in Bioscience (Scholar Edition). 1: 466-76. PMID 19482714  1
2009 Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Matà S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Annals of Neurology. 65: 424-34. PMID 19338055 DOI: 10.1002/ana.21589  1
2009 Tsou AY, Friedman LS, Wilson RB, Lynch DR. Pharmacotherapy for Friedreich ataxia. Cns Drugs. 23: 213-23. PMID 19320530 DOI: 10.2165/00023210-200923030-00003  1
2008 Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet. Neurology. 7: 1091-8. PMID 18851928 DOI: 10.1016/S1474-4422(08)70224-2  1
2008 Myers LM, Lynch DR, Farmer JM, Friedman LS, Lawson JA, Wilson RB. Urinary isoprostanes in Friedreich ataxia: lack of correlation with disease features. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1920-2. PMID 18671287 DOI: 10.1002/mds.22038  1
2008 Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews K, Wilson RB, Balcer LJ, Lynch DR. Health related quality of life measures in Friedreich Ataxia. Journal of the Neurological Sciences. 272: 123-8. PMID 18571673 DOI: 10.1016/j.jns.2008.05.009  1
2008 Stolle CA, Frackelton EC, McCallum J, Farmer JM, Tsou A, Wilson RB, Lynch DR. Novel, complex interruptions of the GAA repeat in small, expanded alleles of two affected siblings with late-onset Friedreich ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1303-6. PMID 18464277 DOI: 10.1002/mds.22012  1
2008 Lagier-Tourenne C, Tazir M, López LC, Quinzii CM, Assoum M, Drouot N, Busso C, Makri S, Ali-Pacha L, Benhassine T, Anheim M, Lynch DR, Thibault C, Plewniak F, Bianchetti L, et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. American Journal of Human Genetics. 82: 661-72. PMID 18319074 DOI: 10.1016/j.ajhg.2007.12.024  1
2008 Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR, Singhal BS, Harding C, Amartino H, Brown CM, Chan A, Renaud D, Geraghty M, et al. Genetic and clinical heterogeneity in eIF2B-related disorder. Journal of Child Neurology. 23: 205-15. PMID 18263758 DOI: 10.1177/0883073807308705  1
2008 Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR. Antioxidant use in Friedreich ataxia. Journal of the Neurological Sciences. 267: 174-6. PMID 17988688 DOI: 10.1016/j.jns.2007.10.008  1
2007 Lynch DR, Farmer JM, Wilson RB. Mortality in Friedreich's Ataxia. Texas Heart Institute Journal / From the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital. 34: 502-3; author reply . PMID 18172544  1
2007 O'Donnell LA, Agrawal A, Sabnekar P, Dichter MA, Lynch DR, Kolson DL. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. Journal of Neurochemistry. 102: 1905-17. PMID 17767704 DOI: 10.1111/j.1471-4159.2007.04645.x  1
2007 Babady NE, Carelle N, Wells RD, Rouault TA, Hirano M, Lynch DR, Delatycki MB, Wilson RB, Isaya G, Puccio H. Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments. Molecular Genetics and Metabolism. 92: 23-35. PMID 17596984 DOI: 10.1016/j.ymgme.2007.05.009  1
2007 Lynch DR, Braastad CD, Nagan N. Ovarian failure in ataxia with oculomotor apraxia type 2. American Journal of Medical Genetics. Part A. 143: 1775-7. PMID 17593543 DOI: 10.1002/ajmg.a.31816  1
2007 Wu HY, Hsu FC, Gleichman AJ, Baconguis I, Coulter DA, Lynch DR. Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. The Journal of Biological Chemistry. 282: 20075-87. PMID 17526495 DOI: 10.1074/jbc.M700624200  1
2007 Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nature Clinical Practice. Neurology. 3: 291-6. PMID 17479076 DOI: 10.1038/ncpneuro0493  1
2007 Waxman EA, Baconguis I, Lynch DR, Robinson MB. N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. The Journal of Biological Chemistry. 282: 17594-607. PMID 17459877 DOI: 10.1074/jbc.M702278200  1
2007 Lynch DR, Gleichman AJ. Picking up the pieces: the roles of functional remnants of calpain-mediated proteolysis. Neuron. 53: 317-9. PMID 17270728 DOI: 10.1016/j.neuron.2007.01.014  1
2007 Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 61: 25-36. PMID 17262855 DOI: 10.1002/ana.21050  1
2006 Robin NH, Taylor CJ, McDonald-McGinn DM, Zackai EH, Bingham P, Collins KJ, Earl D, Gill D, Granata T, Guerrini R, Katz N, Kimonis V, Lin JP, Lynch DR, Mohammed SN, et al. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. American Journal of Medical Genetics. Part A. 140: 2416-25. PMID 17036343 DOI: 10.1002/ajmg.a.31443  1
2006 Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, Nakashima A, Nagatsu T, Ota A, Ischiropoulos H. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10068-78. PMID 17005870 DOI: 10.1523/JNEUROSCI.0896-06.2006  1
2006 Wu HY, Lynch DR. Calpain and synaptic function. Molecular Neurobiology. 33: 215-36. PMID 16954597 DOI: 10.1385/MN:33:3:215  1
2006 Dong YN, Wu HY, Hsu FC, Coulter DA, Lynch DR. Developmental and cell-selective variations in N-methyl-D-aspartate receptor degradation by calpain. Journal of Neurochemistry. 99: 206-17. PMID 16899064 DOI: 10.1111/j.1471-4159.2006.04096.x  1
2006 O'Donnell LA, Agrawal A, Jordan-Sciutto KL, Dichter MA, Lynch DR, Kolson DL. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 981-90. PMID 16421318 DOI: 10.1523/JNEUROSCI.4617-05.2006  1
2005 Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. The Journal of Biological Chemistry. 280: 29322-33. PMID 15967799 DOI: 10.1074/jbc.M502080200  1
2005 Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, Lee VM, Trojanowski JQ, Lynch DR. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry. 44: 7818-29. PMID 15909996 DOI: 10.1021/bi047846q  1
2005 Bearden CE, Jawad AF, Lynch DR, Monterossso JR, Sokol S, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome. Child Neuropsychology : a Journal On Normal and Abnormal Development in Childhood and Adolescence. 11: 109-17. PMID 15846854 DOI: 10.1080/09297040590911239  1
2005 Lynch DR, Farmer JM, Wilson RL, Balcer LJ. Performance measures in Friedreich ataxia: potential utility as clinical outcome tools. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 777-82. PMID 15747359 DOI: 10.1002/mds.20449  1
2005 Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 11: 37-49. PMID 15632277 DOI: 10.1177/1073858404269012  1
2005 Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, Englander SW, Axelsen PH, Giasson BI. The E46K mutation in alpha-synuclein increases amyloid fibril formation. The Journal of Biological Chemistry. 280: 7800-7. PMID 15632170 DOI: 10.1074/jbc.M411638200  1
2004 Dong YN, Waxman EA, Lynch DR. Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11035-45. PMID 15590920 DOI: 10.1523/JNEUROSCI.3722-04.2004  1
2004 Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, Lee VM, Ischiropoulos H. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. The Journal of Biological Chemistry. 279: 47746-53. PMID 15364911 DOI: 10.1074/jbc.M408906200  1
2004 Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. The American Journal of Psychiatry. 161: 1700-2. PMID 15337663 DOI: 10.1176/appi.ajp.161.9.1700  1
2003 Simpkins KL, Guttmann RP, Dong Y, Chen Z, Sokol S, Neumar RW, Lynch DR. Selective activation induced cleavage of the NR2B subunit by calpain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11322-31. PMID 14672996  1
2003 Connelly T, Farmer JM, Lynch DR, Doty RL. Olfactory dysfunction in degenerative ataxias. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 1435-7. PMID 14570842 DOI: 10.1136/jnnp.74.10.1435  1
2003 Mishizen-Eberz AJ, Guttmann RP, Giasson BI, Day GA, Hodara R, Ischiropoulos H, Lee VM, Trojanowski JQ, Lynch DR. Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro. Journal of Neurochemistry. 86: 836-47. PMID 12887682 DOI: 10.1046/j.1471-4159.2003.01878.x  1
2003 Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 804-12. PMID 12815660 DOI: 10.1002/mds.10430  1
2002 Lynch DR, Farmer J. Practical approaches to neurogenetic disease. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 22: 297-304. PMID 12464734  1
2002 Lynch DR, Farmer JM, Rochestie D, Balcer LJ. Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 22: 270-4. PMID 12464730  1
2002 Lynch DR, Farmer JM. Neurogenetics. Introduction. Neurologic Clinics. 20: xi-xii. PMID 12432822 DOI: 10.1016/S0733-8619(02)00006-3  1
2002 Guttmann RP, Sokol S, Baker DL, Simpkins KL, Dong Y, Lynch DR. Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. The Journal of Pharmacology and Experimental Therapeutics. 302: 1023-30. PMID 12183659 DOI: 10.1124/jpet.102.036962  1
2002 Lynch DR, Farmer JM, Balcer LJ, Wilson RB. Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. Archives of Neurology. 59: 743-7. PMID 12020255  1
2002 Lynch DR, Lech G, Farmer JM, Balcer LJ, Bank W, Chance B, Wilson RB. Near infrared muscle spectroscopy in patients with Friedreich's ataxia. Muscle & Nerve. 25: 664-73. PMID 11994959 DOI: 10.1002/mus.10077  0.44
2002 Lynch DR, Guttmann RP. Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 300: 717-23. PMID 11861773 DOI: 10.1124/jpet.300.3.717  1
2002 Licht DJ, Lynch DR. Juvenile dentatorubral-pallidoluysian atrophy: new clinical features. Pediatric Neurology. 26: 51-4. PMID 11814736 DOI: 10.1016/S0887-8994(01)00346-0  1
2001 Raol YH, Lynch DR, Brooks-Kayal AR. Role of excitatory amino acids in developmental epilepsies Mental Retardation and Developmental Disabilities Research Reviews. 7: 254-260. PMID 11754519 DOI: 10.1002/mrdd.1035  1
2001 Lynch DR, Guttmann RP. NMDA receptor pharmacology: Perspectives from molecular biology Current Drug Targets. 2: 215-231. PMID 11554549 DOI: 10.2174/1389450013348434  1
2001 Grant ER, Guttmann RP, Seifert KM, Lynch DR. A region of the rat N-methyl-D-aspartate receptor 2A subunit that is sufficient for potentiation by phorbol esters. Neuroscience Letters. 310: 9-12. PMID 11524145 DOI: 10.1016/S0304-3940(01)02085-7  1
2000 Wilson RB, Lynch DR, Farmer JM, Brooks DG, Fischbeck KH. Increased serum transferrin receptor concentrations in Friedreich ataxia. Annals of Neurology. 47: 659-61. PMID 10805340 DOI: 10.1002/1531-8249(200005)47:5<659::AID-ANA17>3.0.CO;2-T  1
1998 Grant ER, Bacskai BJ, Anegawa NJ, Pleasure DE, Lynch DR. Opposing contributions of NR1 and NR2 to protein kinase C modulation of NMDA receptors. Journal of Neurochemistry. 71: 1471-81. PMID 9751180  1
1998 Brimecombe JC, Gallagher MJ, Lynch DR, Aizenman E. An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors. The Journal of Pharmacology and Experimental Therapeutics. 286: 627-34. PMID 9694913  1
1998 Wilson RB, Lynch DR, Fischbeck KH. Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia. Annals of Neurology. 44: 132-4. PMID 9667602 DOI: 10.1002/ana.410440121  1
1998 Gallagher MJ, Huang H, Lynch DR. Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B- specific interactions Journal of Neurochemistry. 70: 2120-2128. PMID 9572299  1
1997 Gallagher MJ, Huang H, Grant ER, Lynch DR. The NR2B-specific interactions of polyamines and protons with the N-methyl-D-aspartate receptor. The Journal of Biological Chemistry. 272: 24971-9. PMID 9312102 DOI: 10.1074/jbc.272.40.24971  1
1997 Lynch DR, Chance PF. Inherited peripheral neuropathies Neurologist. 3: 277-292.  1
1996 Lynch DR, Gallagher MJ. Inhibition of N-methyl-D-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors Journal of Pharmacology and Experimental Therapeutics. 279: 154-161. PMID 8858988  1
1996 Kendrick SJ, Lynch DR, Pritchett DB. Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits. Journal of Neurochemistry. 67: 608-16. PMID 8764586  1
1996 Gallagher MJ, Huang H, Pritchett DB, Lynch DR. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. The Journal of Biological Chemistry. 271: 9603-11. PMID 8621635  1
1995 Anegawa NJ, Lynch DR, Verdoorn TA, Pritchett DB. Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death. Journal of Neurochemistry. 64: 2004-12. PMID 7722486  1
1994 Lynch DR, Dawson TM. Secondary mechanisms in neuronal trauma Current Opinion in Neurology. 7: 510-516. PMID 7866582  1
1994 Lynch DR, Anegawa NJ, Verdoorn T, Pritchett DB. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Molecular Pharmacology. 45: 540-5. PMID 7511781  1
1992 Lynch DR, Dawson TM, Raps EC, Galetta SL. Risk Factors for the Neurologic Complications Associated with Aortic Aneurysms Archives of Neurology. 49: 284-288. PMID 1311168 DOI: 10.1001/archneur.1992.00530270098025  1
1990 Lynch DR, Braas KM, Mutton JC, Snyder SH. Carboxypeptidase E (CPE): Immunocytochemical localization in the rat central nervous system and pituitary gland Journal of Neuroscience. 10: 1592-1599. PMID 2332799  1
1989 Lynch DR, Walker MW, Miller RJ, Snyder SH. Neuropeptide Y receptor binding sites in rat brain: Differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity Journal of Neuroscience. 9: 2607-2619. PMID 2549216  1
1989 Wilson SK, Lynch DR, Ladenson PW. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: Comparative receptor localization and changes in different hypertension models in the rat Endocrinology. 124: 2799-2808. PMID 2542000  1
1988 Lynch DR, Venable JC, Strittmatter SM, Snyder SH. Enkephalin convertase: characterization and localization using [3H]guanidinoethylmercaptosuccinic acid. Biochimie. 70: 57-64. PMID 3135843 DOI: 10.1016/0300-9084(88)90158-7  1
1988 Lynch DR, Venable JC, Snyder SH. Enkephalin convertase in the heart: Similar disposition to atrial natriuretic factor Endocrinology. 122: 2683-2691. PMID 2967176  1
1987 Lynch DR, Strittmatter SM, Venable JC, Snyder SH. Enkephalin convertase in the gastrointestinal tract an associated organs characterized and localized with [3H]guanidinoethylmercaptosuccinic acid. Endocrinology. 121: 116-26. PMID 3109877 DOI: 10.1210/endo-121-1-116  1
1987 Wilson SK, Lynch DR, Snyder SH. Angiotensin-converting enzyme labeled with [3H]captopril: Tissue localizations and changes in different models of hypertension in the rat Journal of Clinical Investigation. 80: 841-851. PMID 3040809  1
1986 Lynch DR, Strittmatter SM, Venable JC, Snyder SH. Enkephalin convertase: localization to specific neuronal pathways. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 1662-75. PMID 3086516  1
1986 Strittmatter SM, Lynch DR, Snyder SH. Differential ontogeny of rat brain peptidases: prenatal expression of enkephalin convertase and postnatal development of angiotensin-converting enzyme. Brain Research. 394: 207-15. PMID 3021286 DOI: 10.1016/0165-3806(86)90096-9  1
1986 Lynch DR, Snyder SH. Neuropeptides: multiple molecular forms, metabolic pathways, and receptors Annual Review of Biochemistry. 55: 773-799. PMID 3017197  1
1986 Lynch DR, Braas KM, Snyder SH. Atrial natriuretic factor receptors in rat kidney, adrenal gland, and brain: autoradiographic localization and fluid balance dependent changes Proceedings of the National Academy of Sciences of the United States of America. 83: 3357-3361. PMID 3010291  1
1984 Lynch DR, Strittmatter SM, Snyder SH. Enkephalin convertase localization by [3H]guanidinoethylmercaptosuccinic acid autoradiography: selective association with enkephalin-containing neurons. Proceedings of the National Academy of Sciences of the United States of America. 81: 6543-7. PMID 6436816  1
1984 Strittmatter SM, Lynch DR, Snyder SH. [3H]guanidinoethylmercaptosuccinic acid binding to tissue homogenates. Selective labeling of enkephalin convertase. The Journal of Biological Chemistry. 259: 11812-7. PMID 6434531  1
Show low-probability matches.